A long-term survival case of Erdheim-Chester disease on maintenance hemodialysis.


Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
08 2022
Historique:
received: 16 08 2021
accepted: 23 12 2021
pubmed: 4 1 2022
medline: 4 8 2022
entrez: 3 1 2022
Statut: ppublish

Résumé

Erdheim-Chester disease, a rare non-Langerhans histiocytosis, involves multiple organs, including kidney. Renal dysfunction sometimes occurs, and is attributed to ureteral obstruction and renal artery stenosis by histiocytic infiltration. However, to our knowledge, case reports of end-stage renal disease requiring renal replacement therapy due to Erdheim-Chester disease are very few. Here, we report a 69-year-old woman who was diagnosed with Erdheim-Chester disease 10 years ago. She had multiple organ involvement, such as bone, skin, heart, pituitary gland, kidney, and retroperitoneum. She had been treated with interferon-alpha, but discontinued after 2 years due to depression and repeated infection. She did not desire treatment with other drugs, so we continued supportive care. Her renal function gradually deteriorated, and hemodialysis was initiated 4 years ago. Subsequently, she is still doing well without any major symptoms. This report describes an unusual case of Erdheim-Chester disease requiring maintenance hemodialysis that longer prognosis than expected was obtained regardless of multiple organ involvement and no specific treatment after interferon-alpha cessation.

Identifiants

pubmed: 34978674
doi: 10.1007/s13730-021-00680-0
pii: 10.1007/s13730-021-00680-0
pmc: PMC9343548
doi:

Substances chimiques

Interferon-alpha 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-294

Informations de copyright

© 2022. Japanese Society of Nephrology.

Références

Case Rep Transplant. 2020 Jul 13;2020:3954165
pubmed: 32765921
Clin Exp Nephrol. 2012 Oct;16(5):811-2
pubmed: 22864518
Haematologica. 2018 Nov;103(11):1815-1824
pubmed: 29976744
Blood. 2020 Apr 16;135(16):1311-1318
pubmed: 32107533
Int Urol Nephrol. 2010 Dec;42(4):1107-12
pubmed: 20232144
Blood. 2013 Feb 28;121(9):1495-500
pubmed: 23258922
Urology. 2014 Jul;84(1):218-21
pubmed: 24788188
J Neurosurg. 2002 Feb;96(2):344-51
pubmed: 11838810
Blood. 2012 Sep 27;120(13):2700-3
pubmed: 22879539
Blood. 2011 Mar 10;117(10):2778-82
pubmed: 21239701
Ann Rheum Dis. 2015 Aug;74(8):1596-602
pubmed: 24671772
Medicine (Baltimore). 1996 May;75(3):157-69
pubmed: 8965684
Eur J Case Rep Intern Med. 2020 Jun 30;7(9):001630
pubmed: 32908822
Blood. 2014 Jul 24;124(4):483-92
pubmed: 24850756

Auteurs

Ryo Konishi (R)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan. ryo_k0486@yahoo.co.jp.

Takuya Morinishi (T)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan.

Koji Takaori (K)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan.

Yuta Iwamoto (Y)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan.

Makiko Kondo (M)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan.

Sayako Maeda (S)

Department of Nephrology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH